
### [MONDO:0000688](http://purl.obolibrary.org/obo/MONDO_0000688)
**Label:** organic acidemia

**Subclasses:** [MONDO:0015454](http://purl.obolibrary.org/obo/MONDO_0015454) (multiple carboxylase deficiency), [MONDO:0017214](http://purl.obolibrary.org/obo/MONDO_0017214) (vitamin B12-responsive methylmalonic acidemia), [MONDO:0017359](http://purl.obolibrary.org/obo/MONDO_0017359) (3-methylglutaconic aciduria), [MONDO:0016001](http://purl.obolibrary.org/obo/MONDO_0016001) (2-hydroxyglutaric aciduria), [MONDO:0018950](http://purl.obolibrary.org/obo/MONDO_0018950) (3-methylcrotonyl-CoA carboxylase deficiency), [MONDO:0019215](http://purl.obolibrary.org/obo/MONDO_0019215) (classic organic aciduria), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0009563](http://purl.obolibrary.org/obo/MONDO_0009563) (maple syrup urine disease), [MONDO:0017686](http://purl.obolibrary.org/obo/MONDO_0017686) (aminoacylase deficiency), [MONDO:0019213](http://purl.obolibrary.org/obo/MONDO_0019213) (cerebral organic aciduria), [MONDO:0017052](http://purl.obolibrary.org/obo/MONDO_0017052) (intermediate maple syrup urine disease), [MONDO:0009612](http://purl.obolibrary.org/obo/MONDO_0009612) (methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency), [MONDO:0017390](http://purl.obolibrary.org/obo/MONDO_0017390) (methylmalonic acidemia without homocystinuria), [MONDO:0010924](http://purl.obolibrary.org/obo/MONDO_0010924) (d-2-hydroxyglutaric aciduria), [MONDO:0016826](http://purl.obolibrary.org/obo/MONDO_0016826) (methylmalonic acidemia with homocystinuria), [MONDO:0010079](http://purl.obolibrary.org/obo/MONDO_0010079) (Canavan disease), [MONDO:0010327](http://purl.obolibrary.org/obo/MONDO_0010327) (HSD10 disease), 

**Corr. equiv. classes:** [Orphanet:6](http://www.orpha.net/ORDO/Orphanet_6), [Orphanet:289902](http://www.orpha.net/ORDO/Orphanet_289902), [Orphanet:79315](http://www.orpha.net/ORDO/Orphanet_79315), [OMIM:248600](http://purl.obolibrary.org/obo/OMIM_248600), [Orphanet:141](http://www.orpha.net/ORDO/Orphanet_141), [OMIM:271900](http://purl.obolibrary.org/obo/OMIM_271900), [Orphanet:19](http://www.orpha.net/ORDO/Orphanet_19), [OMIM:600721](http://purl.obolibrary.org/obo/OMIM_600721), [Orphanet:26](http://www.orpha.net/ORDO/Orphanet_26), [Orphanet:268162](http://www.orpha.net/ORDO/Orphanet_268162), [OMIM:300438](http://purl.obolibrary.org/obo/OMIM_300438), [Orphanet:27](http://www.orpha.net/ORDO/Orphanet_27), [Orphanet:28](http://www.orpha.net/ORDO/Orphanet_28), [Orphanet:308448](http://www.orpha.net/ORDO/Orphanet_308448), [Orphanet:293355](http://www.orpha.net/ORDO/Orphanet_293355), [Orphanet:79283](http://www.orpha.net/ORDO/Orphanet_79283), [Orphanet:79163](http://www.orpha.net/ORDO/Orphanet_79163), [Orphanet:511](http://www.orpha.net/ORDO/Orphanet_511), [Orphanet:148](http://www.orpha.net/ORDO/Orphanet_148), [OMIM:277410](http://purl.obolibrary.org/obo/OMIM_277410), [Orphanet:391417](http://www.orpha.net/ORDO/Orphanet_391417), [Orphanet:79158](http://www.orpha.net/ORDO/Orphanet_79158), [OMIM:251000](http://purl.obolibrary.org/obo/OMIM_251000), 

**Class expressions from DL-Learner:**

- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 56.34%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 56.34%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001252](http://purl.obolibrary.org/obo/HP_0001252) (Muscular hypotonia) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) 56.34%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0002017](http://purl.obolibrary.org/obo/HP_0002017) (Nausea and vomiting) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 53.87%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0002017](http://purl.obolibrary.org/obo/HP_0002017) (Nausea and vomiting) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 53.87%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 53.87%
- [HP:0001252](http://purl.obolibrary.org/obo/HP_0001252) (Muscular hypotonia) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0002017](http://purl.obolibrary.org/obo/HP_0002017) (Nausea and vomiting) 53.87%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 53.87%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) 53.87%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0002017](http://purl.obolibrary.org/obo/HP_0002017) (Nausea and vomiting) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 53.87%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0002017](http://purl.obolibrary.org/obo/HP_0002017) (Nausea and vomiting) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 53.87%
- [HP:0001252](http://purl.obolibrary.org/obo/HP_0001252) (Muscular hypotonia) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0002017](http://purl.obolibrary.org/obo/HP_0002017) (Nausea and vomiting) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 53.87%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) 53.41%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 53.41%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 53.41%


